Companies Offerings in the Pulmonary Function Testing Systems Market
Everything you need to track the Pulmonary Function Testing Market, organized in one intelligent view - Access the dashboard.
| Company | Description |
| MGC Diagnostics Corporations | Its offerings cover Meridian Series, Ultima PFX, SpiroAir, etc. |
| Vyaire Medical, Inc. | Its portfolio facilitates Vyntus BODY, Vyntus ONE, & Vyntus SPIRO. |
| ndd Medizintechnik AG | A firm has explored TrueFlow ultrasound technology & TrueCheck technology. |
| COSMED Srl | This leader provides pulmonary function testing (PFT) systems, i.e., from portable spirometers to advanced body plethysmographs. |
| Vitalograph | Its offerings comprise VitaloPFT Series, led by ComPAS2 software& the Compact Expert workstation. |
| Schiller AG | This firm offers diversity from portable spirometers to sophisticated, stationary laboratory equipment. |
| KoKo PFT | This has unveiled the KoKo Px series for complete diagnostics & the KoKo Smart/SX1000 spirometers. |
| Midmark Corporation | A company focuses on digital spirometry solutions, especially for point-of-care testing in primary care settings. |
| MIR (Medical International Research) | It offers portable, desktop, and app-based spirometers & oximeters. |
| Geratherm Medical AG | This provides various pulmonary function testing (PFT) systems for clinical & professional applications. |
What are the Key Developments in the Pulmonary Function Testing Systems Market?
- In February 2026, Emirates Health Services (EHS) introduced a novel tool to find respiratory concerns in children at an early stage.
- In February 2026, Zydus Lifesciences Limited launched PEPAIR, India's first cost-effective Oscillating Positive Expiratory Pressure (OPEP) device.
- In February 2025, Visby Medical received 510(k) clearance & was granted a CLIA waiver from the US FDA for its Visby Medical Respiratory Health Test.
Market Trends
The global pulmonary function testing systems market size was estimated at USD 5.3 billion in 2025 and is predicted to increase from USD 5.66 billion in 2026 to approximately USD 10.23 billion by 2035, expanding at a CAGR of 6.8% from 2026 to 2035. The worldwide massive rise in environmental pollution, rising smoking rates & geriatric population are highly susceptible to different respiratory diseases like COPD, asthma, etc. For these cases, leading companies are putting efforts into the development of portable, handheld devices, coupled with AI solutions & home care approaches.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking